Niacin treatment attenuates obesity-induced adipose tissue inflammation through increased adiponectin and anti-inflammatory cytokine expression and reduced pro-inflammatory cytokine expression in a niacin receptor-dependent manner. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.